ArticleDrug delivery2017

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.

Sandhya Pranatharthiharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.